GSK Plc to divest Chiron Behring Vaccines Private Limited (CBVPL), GSK’s Rabies vaccine manufacturing business for India & select other emerging markets to Bharat Biotech India Limited (BBIL)
NovaDhruva acted as an Advisor to GSK Plc
GSK to divest Horlicks and other Consumer Healthcare nutrition products to Unilever
NovaDhruva acted as an Advisor to GSK Plc
Impact on Capital Markets
Sunil Sanghai, founder and CEO of NovaDhruva reflects on Impact of Capital Markets at the CAPAM 2018 held by FICCI
State run Banks: How to let them run
Sunil Sanghai, founder and CEO of NovaDhruva, reflects on urgent corrective measures needed to bring public sector banks back on track.
Odisha Investor Summit
Sunil Sanghai on investment opportunity through private equity
Private Equity – An important source of funding for Indian Companies
Sunil Sanghai on success of private equity in India
NovaDhruva on the Block
NovaDhruva founders caught up with Nisha Poddar of CNBC to discuss the new investment bank on the block NovaDhruva
Vishal Naik
Prior to joining NovaaOne, Vishal has worked with Elara Capital for around 3 years. He has also worked with J.P. Morgan for 4.5 years where he was supporting Global Investment Bankers to create Infographic Presentations. He is an MBA from … Continued
Sunil Sanghai
Sunil Sanghai is an investment banker with over three decades of experience in M&A and capital markets advisory across sectors. Prior to founding NovaaOne, Sunil has been in key leadership positions including Vice Chairman – Investment Banking and Head of … Continued
Hello world!
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!